🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Developing a Methodological Framework and a Dissemination Plan for Herb-drug Interactions-related Clinical Practice Guidelines

Recruitingn/aAges 18 Years - anyAllChinese University of Hong Kong
NCT07248826 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to develop a methodological framework for clinical practice guidelines (CPGs) related to herb-drug interactions (HDIs). It will also learn barriers and facilitators of disseminating HDI-related CPGs and formulate a dissemination plan. The main questions it aims to answer are: 1. develop a methodological framework for HDI-related CPGs using a Delphi method; 2. identity barriers and facilitators of disseminating HDI-related CPGs through semi-structured interviews and formulate a theory-informed dissemination plan to promote the uptake of CPGs locally and internationally. * Participants in the Delphi survey will engage in a consensus development to determine the framework of HDI-related CPGs, including key characteristics and components of this framework. * Participants in the semi-structured interviews will be interviewed on the following top

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Registered Chinese medicine practitioners, herbalists, or researchers in the field of integrated Chinese and Western medicine; * or physicians providing care in integrated Chinese and Western medicine settings; * or healthcare administrators or policymakers from clinics/hospitals directly involved in developing or reviewing clinical practice guidelines related to integrated Chinese and Western medicine. Exclusion Criteria: * Panelists who are unable to commit to participating in all rounds of the Delphi process; * or panelists who are unable to complete the online questionnaire in either Chinese or English; * or panelists who are unable to conduct the interview in either English or Cantonese.
💊

What it tests

  • Delphi method survey
  • Semi-structured interview
📍

Where

1 site
School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
Hong Kong, Hong Kong
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy